Salud
Tribunal alemán suspende el procedimiento de patente de ARNm contra BioNTech
A German court on Thursday suspended patent proceedings against BioNTech over the use of mRNA technology in a COVID-19 vaccine developed by the German company
Gritstone gana un contrato de $433 millones para investigar una vacuna contra el COVID
The US government has awarded Gritstone Biography a $433 million contract to conduct an interim study of a self-amplifying mRNA vaccine candidate against COVID-19. The
McKinsey pagará $230 millones en compensación por opioides en EE.UU.
Consulting firm McKinsey & Co has agreed to pay $230 million to settle lawsuits by hundreds of local governments and school districts in the US
Se aprueba el primer sitio de inyección de drogas supervisado en el Reino Unido
The UK’s first formal controlled drug consumption room was approved on Wednesday to reduce infectious diseases and overdoses in Scotland, which suffers the highest rate
Las muertes por jarabe para la tos han llevado a medidas de prueba de toxicidad más estrictas en EE. UU.
The US FDA is cracking down on lax testing practices by dozens of health product makers after hundreds of deaths overseas from contaminated cough syrups,
Japón ha aprobado el tratamiento Leqembi de Eisai y Biogen para la enfermedad de Alzheimer
Japanese company Eisai has announced that its Alzheimer’s disease treatment developed with Biogen, Leqembi, has been approved by the country’s Ministry of Health, making it
Novartis confirma la escisión de Sandoz el 4 de octubre de 2023
Novartis on Monday confirmed its plans for a 100% spin-off of its Sandoz business on 4 October after shareholders gave their approval earlier this month.
Novo Nordisk y Valo investigarán tratamientos cardiometabólicos
Danish drugmaker Novo Nordisk announced it will collaborate with US technology company Valo Health to discover and develop new treatments for cardiometabolic diseases using human
La FDA de EE. UU. encuentra violaciones en la principal planta estadounidense de Novo en mayo de 2022
Back in May last year, U.S. drug regulators published a report detailing quality control violations at Novo Nordisk’s main North American plant, according to a
El gobierno de EE.UU. ha asignado $45 millones para clínicas COVID a largo plazo
The U.S. government is awarding $45 million in grants to help clinics treating protracted COVID develop new models of care and expand access, the Department